Adma Biologics, Inc.

ADMA

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001368514

SEC filings (opens in a new tab)

No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.

Q4 2021 vs. Q3 2021

How the institutions holding Adma Biologics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of ADMA: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	72	1	88	+17
Shares	41.8M	100	97.2M	+55.4M (+132.6%)
Value	$47.3M	$0	$137.1M	+$89.8M (+189.7%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Adma Biologics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ADMA in Q4 2021
Institution	Shares	Value	% of portfolio
Stonepine Capital Management, LLC	9,911,577	$14.0M	6.41%
Velan Capital Investment Management LP	5,397,798	$7.61M	6.36%
AWM Investment Company, Inc.	4,579,900	$6.46M	0.65%
Maven Securities LTD	3,315,607	$4.67M	0.58%
Altium Capital Management LP	3,300,000	$4.65M	1.31%
Polar Asset Management Partners Inc.	1,287,600	$1.82M	0.02%
Potomac Capital Management, Inc.	775,000	$1.09M	1.05%
Invesco Ltd.	559,926	$789.0K	0.00%
First Hawaiian Bank	513,591	$724.0K	0.02%
Verition Fund Management LLC	503,889	$710.0K	0.01%
683 Capital Management, LLC	303,811	$428.0K	0.02%
Alpine Global Management, LLC	250,000	$353.0K	0.05%
Cubist Systematic Strategies, LLC	187,800	$265.0K	0.00%
Knott David M Jr	152,301	$215.0K	0.08%
D. E. Shaw & Co., Inc.	89,307	$126.0K	0.00%
Virtu Financial LLC	88,315	$125.0K	0.01%
Charles Schwab Investment Management Inc	69,227	$98.0K	0.00%
Lazard Asset Management LLC	39,567	$55.0K	0.00%
Shay Capital LLC	29,404	$41.0K	0.02%
Exane Derivatives	28,348	$40.0K	0.01%
ProShare Advisors LLC	27,576	$39.0K	0.00%
Beacon Pointe Advisors, LLC	27,950	$39.0K	0.00%
Two Sigma Securities, LLC	21,504	$30.0K	0.01%
JPMorgan Chase & Co	17,197	$24.0K	0.00%
State of Wyoming	11,679	$16.0K	0.01%
Tower Research Capital LLC (TRC)	6,566	$9.00K	0.00%
Citigroup Inc	6,006	$8.00K	0.00%
AdvisorNet Financial, Inc	500	$1.00K	0.00%
Aquatic Capital Management LLC	400	$1.00K	0.00%
Cornerstone Advisory, LLC	50	$0	0.00%
Rinkey Investments	100	$0	0.00%

Sold out (14)

Institutions that held Adma Biologics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ADMA in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
HRT Financial LP	118,099	$133.0K
Banco BTG Pactual S.A.	92,500	$105.0K
Newbridge Financial Services Group, Inc.	46,050	$52.0K
Credit Suisse AG	35,000	$40.0K
Hikari Power Ltd	30,075	$34.0K
Stratos Wealth Partners, LTD.	20,000	$23.0K
UBS Group AG	18,435	$21.0K
JustInvest LLC	17,630	$20.0K
XTX Topco Ltd	17,709	$20.0K
Jaffetilchin Investment Partners, LLC	14,250	$16.0K
Royal Bank of Canada	4,195	$5.00K
Plante Moran Financial Advisors, LLC	2,000	$2.00K
Meeder Asset Management Inc	1,008	$1.00K
Sterling Financial Planning, Inc.	100	$0

Not filed for Q4 2021 yet (1)

Institutions that held Adma Biologics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ADMA in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Heritage Wealth Management, LLC	100	$0